TABLE 5.
Characteristics of CAP patients with drug-resistant organisms present in cultures obtained within 48 hours of admission
| Patient 1 | Patient 2 | Patient 3 | |
|---|---|---|---|
| Age | 73 | 62 | 73 |
| Sex | Female | Male | Female |
| Race | Black | Black | White |
| Ethnicity | Non-Hispanic | Non-Hispanic | Hispanic |
| Chronic obstructive pulmonary disease | − | + | − |
| Bronchiectasis | − | + | − |
| Cirrhosis | − | − | − |
| Type 2 diabetes mellitus | − | − | + |
| Chronic kidney disease | − | − | + |
| HIV | − | − | − |
| Immunocompromised | + | − | − |
| Active tobacco use | − | − | − |
| Nursing home or long-term care residence | − | − | − |
| Homelessness | − | − | − |
| Residence in a congregate care facility or group home | − | − | − |
| Prior hospitalization within the last 90 days | + | − | + |
| Previous isolation of MRSA or PsA from any culture (sputum or non-sputum), within 1 year prior to admission | − | − | − |
| Prior IV antibiotics within the last 90 days | + | − | + |
| Co-infections on same admission (influenza or respiratory syncytial virus) | − | − | − |
| Pneumonia severity | Non-severe | Non-severe | Non-severe |
| Initial antibiotic regimen | Vancomycin + piperacillin/tazobactam | Vancomycin + piperacillin/tazobactam + moxifloxacin | Moxifloxacin |
| Results from sputum culture obtained within 48 hours of admission | PsA | PsA | PsA |
| Results from blood culture obtained within 48 hours of admission | No growth | No growth | No growth |
| MRSA nares screening test result | Negative | Not obtained | Not obtained |